BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23841452)

  • 1. B7-H4-Ig treatment of normal mice changes lymphocyte homeostasis and increases the potential of regulatory T cells.
    Kristensen NN; Schmidt EG; Rasmussen S; Balk-Møller E; Claesson MH
    Immunopharmacol Immunotoxicol; 2013 Aug; 35(4):505-13. PubMed ID: 23841452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H4.Ig inhibits the development of type 1 diabetes by regulating Th17 cells in NOD mice.
    Lee IF; Wang X; Hao J; Akhoundsadegh N; Chen L; Liu L; Langermann S; Ou D; Warnock GL
    Cell Immunol; 2013 Mar; 282(1):1-8. PubMed ID: 23623902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
    Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
    Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
    Liu A; Hu P; Khawli LA; Epstein AL
    Clin Cancer Res; 2005 Dec; 11(23):8492-502. PubMed ID: 16322313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
    Elinav E; Waks T; Eshhar Z
    Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway.
    Ou D; Wang X; Metzger DL; Ao Z; Pozzilli P; James RF; Chen L; Warnock GL
    Cell Transplant; 2006; 15(5):399-410. PubMed ID: 16970282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B7-H1 and B7-H4 expression in colorectal carcinoma: correlation with tumor FOXP3(+) regulatory T-cell infiltration.
    Zhao LW; Li C; Zhang RL; Xue HG; Zhang FX; Zhang F; Gai XD
    Acta Histochem; 2014 Sep; 116(7):1163-8. PubMed ID: 25053455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4+CD62L+ T cells which prevent intestinal inflammation in the SCID transfer model of colitis.
    Obermeier F; Strauch UG; Dunger N; Grunwald N; Rath HC; Herfarth H; Schölmerich J; Falk W
    Gut; 2005 Oct; 54(10):1428-36. PubMed ID: 15879013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host B7-H4 regulates antitumor T cell responses through inhibition of myeloid-derived suppressor cells in a 4T1 tumor transplantation model.
    Leung J; Suh WK
    J Immunol; 2013 Jun; 190(12):6651-61. PubMed ID: 23686485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B7-1 and B7-2 differentially control peripheral homeostasis of CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Zeng M; Guinet E; Nouri-Shirazi M
    Transpl Immunol; 2009 Jan; 20(3):171-9. PubMed ID: 18848987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H4 Treatment of T Cells Inhibits ERK, JNK, p38, and AKT Activation.
    Wang X; Hao J; Metzger DL; Ao Z; Chen L; Ou D; Verchere CB; Mui A; Warnock GL
    PLoS One; 2012; 7(1):e28232. PubMed ID: 22238573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B7-H4 induces donor-specific tolerance in mouse islet allografts.
    Wang X; Hao J; Metzger DL; Mui A; Ao Z; Verchere CB; Chen L; Ou D; Warnock GL
    Cell Transplant; 2012; 21(1):99-111. PubMed ID: 21929869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic B7-H4-Ig expression attenuates concanavalin A-induced hepatic injury.
    Xu JF; Xiao H; Hu GY; Zheng SH; Liu W; Yuan CL; Yang H; Lü J; Zheng F; Wang CY; Gong FL
    Clin Immunol; 2010 Jul; 136(1):30-41. PubMed ID: 20346734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
    Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
    Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and characterization of B7-H4/B7S1/B7x-deficient mice.
    Suh WK; Wang S; Duncan GS; Miyazaki Y; Cates E; Walker T; Gajewska BU; Deenick E; Dawicki W; Okada H; Wakeham A; Itie A; Watts TH; Ohashi PS; Jordana M; Yoshida H; Mak TW
    Mol Cell Biol; 2006 Sep; 26(17):6403-11. PubMed ID: 16914726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells.
    Qian Y; Hong B; Shen L; Wu Z; Yao H; Zhang L
    Cell Tissue Res; 2013 Jul; 353(1):139-51. PubMed ID: 23660627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced expression of B7-H4 on the surface of lung cancer cell by the tumor-associated macrophages: a potential mechanism of immune escape.
    Chen C; Qu QX; Shen Y; Mu CY; Zhu YB; Zhang XG; Huang JA
    Cancer Lett; 2012 Apr; 317(1):99-105. PubMed ID: 22108530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
    Totsuka T; Kanai T; Nemoto Y; Tomita T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Akiba H; Okumura K; Yagita H; Watanabe M
    J Immunol; 2009 May; 182(10):6079-87. PubMed ID: 19414759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of enteroantigen-activated CD4⁺ T cells: effects on proliferation and pathogenicity.
    Belmaáti MS; Claesson MH
    Int Immunol; 2015 Sep; 27(9):419-24. PubMed ID: 26133188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.